Readystate Asset Management LP Buys Shares of 34,173 Healthpeak Properties, Inc. $DOC

Readystate Asset Management LP purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOCFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 34,173 shares of the real estate investment trust’s stock, valued at approximately $731,000.

A number of other hedge funds also recently modified their holdings of DOC. State Street Corp grew its position in shares of Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after purchasing an additional 895,460 shares during the period. JPMorgan Chase & Co. lifted its stake in Healthpeak Properties by 8.6% in the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after buying an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Healthpeak Properties by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after buying an additional 123,274 shares during the period. Finally, Invesco Ltd. boosted its holdings in shares of Healthpeak Properties by 9.9% in the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after buying an additional 1,648,012 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

NYSE DOC opened at $20.65 on Tuesday. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The firm’s fifty day moving average price is $21.53 and its two-hundred day moving average price is $19.37. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $22.95. The firm has a market capitalization of $14.24 billion, a P/E ratio of 59.00, a price-to-earnings-growth ratio of 2.55 and a beta of 1.01.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. The company had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company’s quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts anticipate that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.9%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on DOC. Citigroup increased their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 11th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price for the company. in a report on Monday, May 11th. Royal Bank Of Canada lifted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Finally, Cantor Fitzgerald boosted their price target on Healthpeak Properties from $20.00 to $23.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Four analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and a consensus target price of $21.72.

Read Our Latest Report on Healthpeak Properties

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Read More

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.